Epithelial to Mesenchymal Transition Marker in 2D and 3D Colon Cancer Cell Cultures in the Presence of Laminin 332 and 411


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

The loss of apical-basal cell polarity is a necessary stage of the epithelial-mesenchymal transition (EMT). Polarized epithelial cells interact with the basement membrane (BM) and, in particular, with laminins, the major components of BM. Here, we examined the effect of the transition of colon cancer cells from 2D polarized state to non-polarized 3D state on the expression of EMT associated genes, as well as the role of laminins 332 and 411 (LM-332 and LM-411) in this process. The three studied cell lines, HT-29, HCT-116 and RKO, were found to have different sensitivity to cultivation conditions (2D to 3D changes) and to addition of laminins. One of the possible reasons for this may be a difference in the initial 2D state of the cells. In particular, it was shown that the cell lines were at different EMT stages. HT-29 exhibited more epithelial expression profile, RKO was more mesenchymal, and HCT-116 was in an intermediate state. The most laminin-sensitive cell line was HCT-116. The magnitude and the specificity of cell response to LM-332 and LM-411 depended on the expression pattern of laminins’ receptors. EMT gene expression profile was not substantially changed neither during the transition from 2D to 3D state, nor the presence of laminins’ isoforms. However, we detected changes in expression of SNAI1 and ZEB1 genes encoding transcription factors that control the EMT process. Notably, in all three studied cell lines, the expression of SNAI1 was enhanced in response to laminin treatment.

作者简介

D. Maltseva

SRC Bioclinicum; Hertsen Moscow Oncology Research Center, Branch of Federal State Budgetary Institution National Medical Research Radiological Center of the Ministry of Healthcare of the Russian Federation

编辑信件的主要联系方式.
Email: dmaltseva@gmail.com
俄罗斯联邦, Moscow, 115088; Obninsk, 249036

J. Makarova

Hertsen Moscow Oncology Research Center, Branch of Federal State Budgetary Institution National Medical Research Radiological Center of the Ministry of Healthcare of the Russian Federation; Institute of Molecular Biology, Russian Academy of Sciences

Email: dmaltseva@gmail.com
俄罗斯联邦, Obninsk, 249036; Moscow, 119991

A. Khristichenko

SRC Bioclinicum

Email: dmaltseva@gmail.com
俄罗斯联邦, Moscow, 115088

I. Tsypina

SRC Bioclinicum; National Research University Higher School of Economics

Email: dmaltseva@gmail.com
俄罗斯联邦, Moscow, 115088; Moscow, 101000

E. A. Tonevitsky

SRC Bioclinicum

Email: dmaltseva@gmail.com
俄罗斯联邦, Moscow, 115088

S. Rodin

SRC Bioclinicum; Department of Medical Biochemistry and Biophysics, Karolinska Institute

Email: dmaltseva@gmail.com
俄罗斯联邦, Moscow, 115088; Stockholm, SE 17177

补充文件

附件文件
动作
1. JATS XML

版权所有 © Pleiades Publishing, Inc., 2019